The use of gabapentin enacarbil in the treatment of restless legs syndrome

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Xp13512/Gsk1838262 in the Treatment of Patients With Primary Restless Legs Syndrome

(2017) Clete A. Kushida et al.   SLEEP

Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome

(2010) Michael Saletu et al.   JOURNAL OF NEURAL TRANSMISSION

Gabapentin Enacarbil in Restless Legs Syndrome

(2009) Arthur S. Walters et al.   CLINICAL NEUROPHARMACOLOGY

Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers

(2009) Ritu Lal et al.   CLINICAL THERAPEUTICS

Restless Legs Syndrome

(2009) William G. Ondo   NEUROLOGIC CLINICS

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS

(2009) C. A. Kushida et al.   NEUROLOGY

Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin

(2008) Kenneth C. Cundy et al.   JOURNAL OF CLINICAL PHARMACOLOGY

PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome

(2008) Barbara Schormair et al.   NATURE GENETICS